Day: December 12, 2022

AMREP Reports Second Quarter Fiscal 2023 Results

AMREP Reports Second Quarter Fiscal 2023 Results

HAVERTOWN, Pa., Dec. 12, 2022 (GLOBE NEWSWIRE) — AMREP Corporation (NYSE:AXR) today reported net income of $3,621,000, or $0.68 per diluted share, for its 2023 fiscal second quarter ended October 31, 2022 compared to net income of $3,326,000, or $0.45 per diluted share, for the same period of the prior year. For the first six months of 2023, AMREP had net income of $5,533,000, or $1.04 per diluted share, compared to net income of $4,963,000, or $0.67 per diluted share, for the same period of 2022. Revenues were $16,149,000 and $26,856,000 for the second quarter and first six months of 2023 and $16,112,000 and $26,098,000 for the second quarter and first six months of 2022. More information about the Company’s financial performance may be found in AMREP Corporation’s financial statements on Form 10-Q which have today been filed...

Continue reading

Lion Electric Announces Launch of Overnight Marketed Public Offering of Units

Lion Electric Announces Launch of Overnight Marketed Public Offering of Units

This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated June 17, 2022 to its short form base shelf prospectus dated June 17, 2022. MONTREAL, Dec. 12, 2022 (GLOBE NEWSWIRE) — The Lion Electric Company (NYSE: LEV) (TSX: LEV) (“Lion” or the “Company”), a leading manufacturer of all-electric medium and heavy-duty urban vehicles, today announced the launch of a marketed public offering of units (the “Units”) in the United States and Canada (the “Offering”). Each Unit will consist of one common share in the capital of the Company (each a “Unit Share”) and one common share purchase warrant (each a “Warrant”). Each whole Warrant will entitle the holder thereof to acquire one common share in...

Continue reading

Carriage Services Announces High Performance and Credit Profile Restoration Plan

Carriage Services Announces High Performance and Credit Profile Restoration Plan

Conference call on Tuesday, December 13, 2022, at 9:30 a.m. Central Time HOUSTON, Dec. 12, 2022 (GLOBE NEWSWIRE) — Carriage Services, Inc. (NYSE: CSV) today made several important announcements. The Company will host a conference call on Tuesday, December 13, 2023 at 9:30 a.m. Central Standard Time to discuss this press release. Announcing High Performance and Credit Profile Restoration Plan (“HPCPRP”); Announcing Definitive Agreement to acquire Greenlawn Funeral Homes and Cemeteries in Bakersfield, CA (“Greenlawn”); Announcing 2024 Goals for Performance Metrics including Total Revenue of $390 million to $400 million, Consolidated EBITDA of $120 million to $126 million, GAAP Net Income of $46 million to $50 million, GAAP Diluted EPS of $2.95 to $3.05 per share, and a deleveraging goal of 4.0 times to 4.3 times Total Debt to Consolidated...

Continue reading

Greystone Housing Impact Investors LP Rings Opening Bell at New York Stock Exchange to Commemorate New Name and Listing

Greystone Housing Impact Investors LP Rings Opening Bell at New York Stock Exchange to Commemorate New Name and Listing

Greystone Housing Impact Investors LP listed on NYSE Jesse Coury of GHI; Stephen Rosenberg of Greystone; Jeff Baevsky of Greystone; Representatives of NYSE; Ken Rogozinski of GHI; Drew Fletcher of Greystone Greystone Housing Impact Investors LP rings opening bell at NYSE Greystone Housing Impact Investors LP rings opening bell at NYSE on December 12, 2022 Greystone Housing Impact Investors LP listed on NYSE Greystone Housing Impact Investors LP rings the opening bell on NYSE on December 12, 2022. Greystone Housing Impact Investors LP rings opening bell at NYSE Back row: Deborah Wilson, GHI Board Member; John Tuttle, Vice Chairman, NYSE; Stephen Rosenberg, Founder & Executive Chairman, Greystone; Ken Rogozinski, CEO, Greystone Housing Impact Investors LP; Lisa Schwartz, General Counsel, Greystone; Drew Fletcher, GHI Board Member...

Continue reading

JOANN Announces Third Quarter Fiscal 2023 Results

JOANN Announces Third Quarter Fiscal 2023 Results

7.9% decline in net sales accompanied by a strong 8% increase in Halloween item performance Targeting $200 million of cost savings from lower supply chain, product costs, and other operating expenses to maximize cash generation and liquidity in a challenging macro environment Pausing quarterly dividend to improve operational flexibility and strengthen balance sheet HUDSON, Ohio, Dec. 12, 2022 (GLOBE NEWSWIRE) — JOANN Inc. (NASDAQ: JOAN) (“JOANN”), the nation’s category leader in sewing and one of the fastest growing competitors in the arts and crafts category, today reported results for its third quarter ending October 29, 2022. “Although we had a very good sell through during Halloween and are encouraged by our recent momentum during Black Friday and Cyber Monday, it’s clear that consumers are increasingly pressured by inflation...

Continue reading

Almadex intersects 1.3 metres of 846.0 g/t Silver at the San Pedro Silver-Gold Project, Mexico

Almadex intersects 1.3 metres of 846.0 g/t Silver at the San Pedro Silver-Gold Project, Mexico

San Pedro Property Location Map San Pedro Property Drill Plan Map San Pedro Property Section SP-22-004 VANCOUVER, British Columbia, Dec. 12, 2022 (GLOBE NEWSWIRE) — Almadex Minerals Ltd. (“Almadex” or the “Company”) (TSX-V: “DEX) is pleased to announce that it has received results from the second hole (SP-22-004) drilled in 2022 on its wholly owned San Pedro Project located in Jalisco, Mexico (Figure 1). This hole was drilled from the same pad as hole SP-22-003 which intersected 4.51 metres of 656.8 g/t silver at the collar (see Almadex news release of December 6th, 2022). Hole SP-22-003 was drilled with an inclination of -50 degrees, while SP-22-004 was drilled with -75 degrees. Hole SP-22-004 appears to have intersected an old mining excavation from 1.1 to 3.1 meters, which was not apparent on surface...

Continue reading

Constellation Software Inc. and Lumine Group Inc. reach agreement to acquire WideOrbit Inc. and file preliminary prospectus in connection with proposed Lumine Group Spin Out

Constellation Software Inc. and Lumine Group Inc. reach agreement to acquire WideOrbit Inc. and file preliminary prospectus in connection with proposed Lumine Group Spin Out

TORONTO, Dec. 12, 2022 (GLOBE NEWSWIRE) — Constellation Software Inc. (“Constellation”) (TSX:CSU) and its subsidiary Lumine Group Inc. (“Lumine Group”) announced today that they have entered into a binding agreement and plan of merger with WideOrbit Inc. (“WideOrbit”), a U.S.-based media vertical market software provider. Once the transaction is completed, WideOrbit will become a wholly owned subsidiary within Lumine Group and will operate as an autonomous business unit within the Lumine Group’s portfolio of companies.   In addition, Constellation announced today that a preliminary prospectus has been filed in all provinces and territories of Canada in connection with the proposed distribution of the shares of Lumine Group Inc. which entity is expected to be spun out of Constellation and will operate as a separate publicly traded...

Continue reading

ORYZON Presents Final Data From Phase IIa ALICE Trial in Unfit AML Patients with First-line Treatment of Iadademstat and Azacitidine in Oral Presentation at ASH-2022

ORYZON Presents Final Data From Phase IIa ALICE Trial in Unfit AML Patients with First-line Treatment of Iadademstat and Azacitidine in Oral Presentation at ASH-2022

Robust, rapid and durable efficacy – ORR 81%, of which 64% are CR/CRi 68% of CR/CRi lasting more than 6 months Longest remission + 3 years Iadademstat and azacitidine combination shows a good safety profile Dosing of iadademstat established at 90 μg/m2/d Responses in patients with a diverse array of AML mutations, including FLT3 or TP53 mutations, and in monocytic AML subtypes MADRID, Spain and BOSTON, Dec. 12, 2022 (GLOBE NEWSWIRE) — Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, today presents the final data from its Phase IIa ALICE trial, investigating iadademstat in combination with azacitidine in elderly or unfit patients with acute myeloid leukemia (AML), at the 64th American...

Continue reading

Absecon Bancorp Announces Annual Cash Dividend of $2.20 Per Share

Absecon Bancorp Announces Annual Cash Dividend of $2.20 Per Share

ABSECON, N.J., Dec. 12, 2022 (GLOBE NEWSWIRE) — Absecon Bancorp (the “Company”) (OTC, trading as ASCN), the bank holding company of First National Bank of Absecon, an Atlantic County New Jersey based community bank, announced today that its Board of Directors authorized a cash dividend in the amount of $2.20 per share on November 22, 2022. “This dividend represents a 4.76% increase over last year’s regular cash dividend and is consistent with our long-term capital management policies and our commitment to our stockholders. We will continue to prudently invest in our business, buyback our stock when it makes economic sense, and distribute the rewards of those investments to our stockholders over time,” said C. Eric Gaupp, President and CEO of Absecon Bancorp. As part of the capital management plan, today’s announcement of an annual...

Continue reading

Mydecine Innovations Group Closes Sale of Its Wholly-Owned Subsidiary, Mindleap Health Inc.

Mydecine Innovations Group Closes Sale of Its Wholly-Owned Subsidiary, Mindleap Health Inc.

DENVER, Dec. 12, 2022 (GLOBE NEWSWIRE) — Mydecine Innovations Group Inc. (“Mydecine” or the “Company”) (NEO:MYCO) (OTC:MYCOF) (FSE:0NFA) a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly address addiction and mental health, is pleased to announce that, further to its news release dated September 1, 2022, it has closed the sale of all of the issued and outstanding shares of its wholly-owned subsidiary, Mindleap Health Inc. (“Mindleap”), to PanGenomic Health Inc. (“PanGenomic”), a company listed on the Canadian Stock Exchange (the “CSE”). The sale of Mindleap is a significant step towards refocusing the Company’s resources on its primary strategy of discovering and developing innovative pharmaceutical psychedelic substances to meet the unmet needs of millions of...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.